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In this issue of Neuron, Hu et al. (2012) report that upon axonal damage, CHOP and XBP1 unfolded protein
response pathways are not recruited equally and have opposite effects on neuronal survival. XBP1 pathway
boosting may represent a valuable neuroprotective strategy.Endoplasmic reticulum (ER) homeostasis,
protein synthesis, and protein quality
control processes are tightly coordinated
events that together ensure a smooth
and adequate flow of proteins through
cellular compartments, without build-up
of misfolded or unfolded proteins. In
mammalian cells, disturbances in ER ho-
meostasis trigger three distinct adaptive
signaling pathways (Figure 1). First, the
accumulation of unfolded proteins acti-
vates the ER-resident kinase PERK,
whose major substrate is the translation
initiation factor eiF2a. Upon phosphory-
lation of eiF2a, translation is inhibited,
thus reducing the load on the folding
machinery. In parallel, eiF2a phosphoryla-
tion stimulates the translation of a specific
subset of mRNAs, including that encoding
the transcription factor ATF4. In turn,
ATF4 drives the transcription of several
critical genes including CHOP, the tran-
scription factor that can trigger the
expression of pro-apoptotic genes. A
second pathway relies on the bifunctional
transmembrane kinase-endonuclease
IRE1. Upon detecting unfolded proteins
in the ER lumen, IRE1 undergoes multi-
merization and autophosphorylation,
which activates its ribonuclease domain.
Active IRE1 is responsible for the uncon-
ventional splicing of the mRNA coding
for XBP1: when activated, IRE1 ribonu-
clease removes the intron in XBP1
mRNA, allowing the mRNA to properly
code for XBP1, a transcription factor that
upregulates ER membrane biosynthesis,
ER chaperones, and ER-associated de-
gradation complexes. A third system is
based on the cleavage of the transmem-
brane domain of the transcription factor
ATF6. Two proteases cleave and release
active ATF6 during its transit through
the Golgi apparatus, and the N-terminal
ATF6 domain is then free to translocateto the nucleus where it is a potent inducer
of chaperone proteins transcription.
While in yeast the IRE-XBP pathway
is responsible for the unfolded protein
response (UPR); in mammalian cells all
three pathways are involved and have
partially overlapping roles (for a review
see Walter and Ron, 2011). In nonneuro-
nal cells, triggering a UPR leads to the
activation of all three pathways. Of note,
a UPR is not induced only as a conse-
quence of acute ER stress, but also as
part of a more complex cellular strategy
for coping with increased secretory or
metabolic requirements, as for example
observed in immunoglobulin-secreting
plasma cells and in exocrine pancreas
(Rutkowski and Hegde, 2010).
The outcome of the UPR is primarily
protective, helping cells to survive tempo-
rary excesses in protein synthesis re-
quirements or loads of unfolded proteins.
However, the UPR triggers apoptosis
when restoration of homeostasis is not
achieved, and when activation exceeds
a threshold in intensity or duration. Ac-
cordingly, the same signaling pathways
can be anti- or pro-apoptotic depending
on the trigger, intensity, and cellular
context of UPR activation (Han et al.,
2009).
Hu et al. describe a strikingly divergent
role of UPR signaling pathways in retinal
ganglion cell (RGC) survival and death
upon axonal injury. Following three un-
related optic nerve injuring treatments
(optic nerve crush, vincristine-induced
optic neuropathy, or intraocular hyper-
tension (IOP) mimicking open-angle glau-
coma), they identify in retrogradely
labeled RGCs a characteristic pattern of
UPR activation: a marked and sustained
upregulation of CHOP-dependent UPR,
along with a lesser and more transient
activation of XBP1 splicing (Figure 1). InNeuron 73parallel, the optic nerve injury protocols
produce major losses of RGCs. Notably,
optic nerve crush in CHOP KO mice re-
sulted in a major increase in RGC survival,
whereas retinal knockdown of XBP1 did
not rescue RGC apoptosis. Conversely,
AAV-mediated overexpression of spliced
(s) XBP1 dramatically preserved RGC
survival, with even greater effects de-
tected in a CHOP-KO background. Most
notably, the protective effect of sXBP1
overexpression was detected in clinically
meaningful conditions, such as when
AAV injection was performed subsequent
to the experimental establishment of IOP.
Unfortunately, these manipulations im-
proved RGC survival but did not promote
axonal regeneration. Hu et al. thus identify
two at least partially independent UPR
pathways triggered upon axonal injury
that have opposite roles in determining
the fate of RGCs: PERK-CHOP signaling
results in RGC apoptosis, whereas XBP1
stimulates cell survival (Figure 1). Notably,
in the course of mechanical or pharma-
cological damage to the optic nerve,
modest sXBP1 upregulation appears to
be insufficient to counteract CHOP ex-
pression, and RGCs undergo extensive
apoptosis.
Hu et al.’s results suggest that in
neurons a UPR can be an intrinsic re-
sponse to disturbances in axonal integrity
and flow, possibly unrelated to the load
of un/misfolded proteins and part of
a general response strategy to axotomy
(see also Saxena et al., 2009). One possi-
bility is that, in this context, the UPRmight
be triggered by a specific lesion signal (or
the lack of an ‘‘integrity signal’’) generated
in the injured axon, to remodel the ER and
spur regeneration. The identity and in-
deed existence of such signals remains
to be determined. In principle, the UPR
response may be directly triggered by, February 9, 2012 ª2012 Elsevier Inc. 405
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Figure 1. Recruitment of Distinct UPR Pathways Promoting Neuronal Survival and Death
upon Axon Damage
Hu et al. (2012) show that upon axonal damage due to optic nerve crush, intraocular vincristine or
intraocular hypertension, extensive apoptosis of retinal ganglion cells is the result of the activation of
UPR. A robust and sustained activation of the ATF4-CHOP cascade promotes axotomy-induced
apoptosis, which is much reduced in CHOP/ mice. In parallel, a lesser and transient activation of
the IRE-XBP1 pathway has protective effects, and AAV-mediated XBP1 overexpression counteracts
axotomy-induced RGC apoptosis. The nature of the local and retrograde signaling leading to UPR induc-
tion is unknown, as are the effector mechanisms for CHOP-dependent apoptosis and XBP1-mediated
neuroprotection.
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tubular membranes in axons, thus pro-
viding potential more general scenarios
in which axonal dysfunction may produce
signaling to the soma to activate repair
responses. Whether and how local ER
dysfunction in the axon influences neu-
ronal UPR responses remains to be deter-
mined. In the specific context of axonal
injury, the UPR response appears to
mainly have a detrimental outcome. Why
the activation of XBP1 splicing is limited,
compared to the robust upregulation of
CHOP, is unclear; the authors speculate
that this may be due to limited amounts
of XBP1 mRNA in the axon itself. Alterna-
tively, local splicing may be inefficient, or
the retrograde signal may not effectively
recruit the IRE-XBP1 pathway. Further-
more, since both IRE1 and PERK are
intrinsic ER membrane proteins, activa-
tion in specific subdomains of the ER
may play a role (Figure 1). Clearly, our
understanding of these pathways in
neurons, including the ATF6 pathway
that was not considered in this context,
is still incomplete. Their investigation in
future studies might yield valuable infor-
mation to translate progress in neuronal
cell biology into more effective strategies
for neuroprotection.
The mechanisms underlying the oppo-
site effects of CHOP and XBP1 pathways
on neuronal survival also remain to be in-
vestigated. The CHOP cascade appears406 Neuron 73, February 9, 2012 ª2012 Elseto have a critical role in UPR-dependent
cell death in neurons (Galehdar et al.,
2010), and nonneuronal cells (Puthalakath
et al., 2007), largely due to the induction of
BH3-only pro-apoptotic proteins such as
bim and puma. By contrast, the neuropro-
tective mechanisms set in motions by
XBP1 are less clearly understood: the in-
duction of ER chaperons (such as BiP,
Grp94, and Grp58) and the stimulation of
ER biogenesis (Walter and Ron, 2011)
may be important, but further targets of
XBP1, possibly including autophagy path-
ways (see e.g., Hetz et al., 2009) may also
have a role.
This study clearly suggests that XBP1
is a valuable neuroprotective target to
counteract neuronal losses and blindness
upon axonal injuries. But the lessons
learned through these axonal damage
studies might have implications beyond
injury-related cell death and neural repair.
Thus, early UPR upregulation is a hallmark
of neurodegenerative diseases (for a
review, see Saxena and Caroni, 2011).
CHOP and XBP1 upregulation has been
described in Alzheimer’s disease, Parkin-
son Disease, ALS models (Kikuchi et al.,
2006), and photoreceptors expressing
mutant rhodopsin (Ryoo et al., 2007)—
and may contribute to the pathogenesis
of prion diseases (Rane et al., 2008).
Notably, XBP1 exerts neuroprotective
effects against amyloid-b induced neu-
ronal death in a Drosophila model,vier Inc.although here XBP1 overexpression
does not affect ER stress per se, but
rather the regulation of cytosolic Ca2+
levels upon downregulation of ryanodine
receptors (Casas-Tinto et al., 2011). Like-
wise, XBP1 is upregulated in chemical
mouse models of PD, and AAV-mediated
XBP1 overexpression in the substantia
nigra is neuroprotective in this condition
(Sado et al., 2009). As a word of caution,
however, XBP1 knockdown can also re-
sult in decreased load of misfolded pro-
teins and neuroprotection (Hetz et al.,
2009), and CHOP upregulation may not
always lead to apoptosis (Halterman
et al., 2010). Accordingly, the outcome
of IRE-XBP1 and CHOP pathway activa-
tion may depend on the identity of the
affected neurons, on context, and on
the specific triggers that induce the
UPR. Clearly, the issues raised by the
results of this elegant study have im-
portant potential implications for our
understanding of how axonal dysfunc-
tion influences neuronal function, repair,
and death under acute and chronic
conditions.REFERENCES
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Oxytocin produces anxiolytic effects via the central nucleus of the amygdala but how the peptide reaches its
receptors in this region has been unclear. In this issue of Neuron, Knobloch et al. (2012) demonstrate that
evoked oxytocin release from axon terminals within the central amygdala results in attenuation of fear.The evolutionarily preserved neuropep-
tide oxytocin (OT) is perhaps best known
for its role as an important hormonal regu-
lator of mammalian reproductive pro-
cesses such as cervical softening, uterine
contraction, and milk ejection. In addition
to these peripheral effects, OT is involved
in functions of the central nervous system.
From enhancing social recognition, pair
bonding, and maternal behavior to re-
ducing stress effects and pain sensi-
tivity, central effects of OT have been
demonstrated in many mammalian spe-
cies (Landgraf and Neumann, 2004). OT
strengthens pair bonding in monogamous
female prairie voles, whereas blocking OT
receptors prevents pair bonding. OT can
induce maternal behavior in virgin rats
whereas rats selectively bred for strong
maternal behavior start to neglect their
pups when central OT receptors are phar-
macologically blocked. In humans, intra-
nasally applied OT attenuates the stress
response induced by public speaking,
and OT release during breast-feeding
lowers stress hormone levels and ele-
vates mood in mothers (Lee et al., 2009).
Interestingly, these anxiolytic effects of
OT have been associated with reduced
neuronal activation in the amygdala, a
key brain structure for anxiety and fear
(LeDoux, 2000). The central nucleus ofthe amygdala (CeA), comprising lateral
(CeL) and medial (CeM) subdivisions,
mediates acquisition and expression of
behavioral as well as autonomic fear re-
sponses (Maren and Quirk, 2004). Strong
OT receptor expression within the CeL
has been reported, and in mice, local
application of OT in the CeA results in
attenuation of conditioned fear responses
(Viviani et al., 2011). However, the way by
which OT reaches the CeA to affect fear
has remained unclear (Neumann, 2007).
Neurons of the paraventricular (PVN),
supraoptic (SON), and accessory magno-
cellular (AN) nuclei of the hypothalamus
synthesize OT and release it via their
axon terminals in the posterior pituitary
from which it enters the blood stream.
Because OT cannot pass the blood-brain
barrier, its effect on CeA function and
subsequent fear behavior must be cen-
trally mediated. Axonal projections of
hypothalamic OT neurons targeting the
limbic system have been reported for
olfactory bulb, septum, and hippocam-
pus, but until now, evidence of OT axonal
fibers within the amygdala has been
limited (Landgraf and Neumann, 2004).
Thus, it was proposed that OT, after
dendritic release either from unidentified
cells in CeA or from magnocellular neu-
rons in the hypothalamus,would passivelydiffuse within the extracellular matrix to
reach distant target regions, including
CeA (Neumann, 2007; Ludwig and Leng,
2006).
In general, there are numerous routes
through which neuropeptides are re-
leased and reach their targets. They can
be secreted over the entire cell membrane
including soma and dendrites into the
extracellular space and ultimately reach
receptors by way of diffusion (Ludwig
and Leng, 2006). Alternatively, neuropep-
tides can be coreleased at synapses
together with classical neurotransmitters
such as GABA or glutamate. Depending
on the amount released and because
of relatively long half-lives due to slow
degradation in the extracellular space,
neuropeptides often spill over from syn-
apses to bind extrasynaptic receptors.
Passive diffusion along concentration
gradients following dendritic release or
synaptic spillover presents a mechanism
through which neuropeptides, such as
OT or vasopressin, without using direct
cell-to-cell connections, can modulate
the activity of their target cells. However,
because these diffusion processes are
both slow and undirected, this comes at
cost of temporal as well as spatial speci-
ficity of neuropetidergic signaling. Focal
release of neuropeptides at synaptic sites, February 9, 2012 ª2012 Elsevier Inc. 407
